ADPT Latest Press Releases

-- October 14, 2026 --

Adaptive Biotechnologies to Report Third Quarter 2026 Financial Results on November 4, 2026 Globe Newswire 4:05 PM

-- September 25, 2026 --

Adaptive Biotechnologies Highlights Role of Highly Sensitive MRD Testing in New International Myeloma Society Definition of Cure Globe Newswire 8:03 AM

-- September 17, 2026 --

Adaptive Biotechnologies Announces Update to NCCN Guidelines for Multiple Myeloma, Strengthening MRD Testing Recommendations and Specifically Referencing clonoSEQ Globe Newswire 8:00 AM

-- September 1, 2026 --

Adaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference Globe Newswire 4:05 PM

-- July 29, 2026 --

Adaptive Biotechnologies Reports Second Quarter 2026 Financial Results Globe Newswire 4:05 PM

-- July 9, 2026 --

Adaptive Biotechnologies to Report Second Quarter 2026 Financial Results on July 29, 2026 Globe Newswire 4:05 PM

-- June 17, 2026 --

Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering Globe Newswire 6:00 AM

-- June 15, 2026 --

Adaptive Biotechnologies Announces Plan to Separate Its MRD and Immune Medicine Businesses Globe Newswire 4:10 PM

Adaptive Biotechnologies Corporation Announces Proposed Convertible Senior Notes Offering Globe Newswire 4:05 PM

-- May 29, 2026 --

At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ MRD Testing Across Hematology Clinical Practice and Research Globe Newswire 7:30 AM

-- May 21, 2026 --

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences Globe Newswire 4:17 PM

Market Data Delayed 15 Minutes